Explore the benefits of the Precision GLP-1 agonist, a new therapy that improves glycaemic control and reduces side effects.
Explore the latest breakthrough in malaria drugs targeting a unique protein essential for the parasite's survival and transmission.
Could targeting a enzyme play a role in slowing lung fibrosis? Boehringer Ingelheim’s research into PDE4B is offering ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results